Site-specific PEGylation of interferon beta-1b
Author:
Publisher
Elsevier
Reference117 articles.
1. Multiple sclerosis and T lymphocytes: an entangled story;Legroux;J Neuroimmune Pharmacol,2015
2. New advances in disease-modifying therapies for relapsing and progressive forms of multiple sclerosis;Vidal-Jordana;Neurol Clin,2018
3. Comparing the efficacy of disease-modifying therapies in multiple sclerosis;Mitsikostas;Mult Scler Relat Disord,2017
4. The innovative development in interferon beta treatments of relapsing-remitting multiple sclerosis;Madsen;Brain and Behavior,2017
5. Beta-interferon for multiple sclerosis;Rudick;Exp Cell Res,2011
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Silk Bioconjugates: From Chemistry and Concept to Application;ACS Biomaterials Science & Engineering;2023-01-27
2. Engineering Strategies for Immunomodulatory Cytokine Therapies: Challenges and Clinical Progress;Advanced Therapeutics;2021-04-02
3. The evolution of polymer conjugation and drug targeting for the delivery of proteins and bioactive molecules;WIREs Nanomedicine and Nanobiotechnology;2020-12-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3